Author

F. Benhamed

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Pathology· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 3 Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

C. Postic· 2 shared A. Batut· 1 shared A. Dortignac· 1 shared A. Grosfeld· 1 shared A. Montagner· 1 shared A. Naviere· 1 shared A. Polizzi· 1 shared A. Yart· 1 shared

Activity by Year

2021-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPhysiology

C. Postic

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Wnt/β-catenin signaling improves oxidative metabolism in skeletal muscle of obese ob/ob mice

E. Christodoulou, C. Lepeigneux, A. Naviere, J. Pujol, F. Benhamed, P. Maire, I. Guillet-Deniau

This study shows that activating Wnt/β-catenin signaling in skeletal muscle of obese mice improves oxidative metabolism and reduces hyperglycemia.

bioRxiv · Jan 23, 2024 · PreprintCell Biology

Loss of intestinal ChREBP impairs absorption of dietary sugars and prevents glycemic excursion curves

W. Charifi, V. Fauveau, L. Francese, A. Grosfeld, M. Le Gall, S. Ourabah, S. Ellero-Simantos, T. Viel, M. Cauzac, D. Gueddouri, F. Benhamed, B. Tavitian, R. Dentin, A.-F. Burnol, C. Postic, S. Guilmeau

This study shows that loss of intestinal ChREBP reduces glucose absorption and delays glycemic responses by impairing sugar transporters and enzymes.

bioRxiv · May 18, 2021 · PreprintPhysiology

Nuclear HMGB1 protects from non-alcoholic fatty liver diseases through negative regulation of liver X receptor

J. Personnaz, E. Piccolo, A. Dortignac, J. S. Iacovoni, J. Mariette, A. Polizzi, A. Batut, S. Deleruyelle, R. Paccoud, E. Moreau, F. Martins, T. Clouaire, F. Benhamed, A. Montagner, W. A. Wahli, , J.-P. Pradere

This study shows that nuclear HMGB1 suppresses liver lipogenesis in NAFLD by inhibiting LXR activity, preventing steatosis and insulin resistance.

bioRxiv · Feb 17, 2021 · PreprintPathology